Diabetes Type Articles & Analysis
44 articles found
If you ignore the snoring and sleep apnea, it can lead to multiple health issues such as hypertension, cardiovascular issues and even Type 2 diabetes. Usually, the gold standard in sleep apnea treatment is CPAP therapy or Continuous Positive Airway Pressure therapy, which helps eliminate the pauses in breathing, as it provides a steady stream of air to your ...
Diabetes is a common clinical disease, and with the improvement of living standards, an increase in the number of obese people, and the intensification of aging populations, the incidence of diabetes is increasing year by year. Diabetes has various types and requires long-term treatment. Antidiabetic drugs are essential for ...
Abstract Background: Assessment of short-term glycemic control can facilitate monitoring of diabetes development in at-risk individuals and monitoring response to lifestyle modification or medication. We evaluated salivary protein glycosylation levels as a novel, noninvasive, short-term glycemic index in comparison to hemoglobin A1c (HbA1c), fructosamine, 1,5-anhydroglucitol ...
Assessment of C-peptide levels can identify individuals at risk for or with type 1 diabetes with residual β-cell function in whom β cell-sparing interventions can be evaluated, and can aid in distinguishing type 2 diabetes from Latent Autoimmune Diabetes in Adults and late-onset type 1 ...
Diabetes, specifically Type 1 and Type 2 Diabetes Mellitus, remains one of the most commonly encountered metabolic diseases worldwide. The complexity and diversity of these conditions necessitate the development of detailed medical models for a comprehensive understanding of the diseases. Over time, Type 1 and ...
The most common forms of diabetes are type 1 diabetes and type 2 diabetes. Type 1 diabetes (once known as insulin-dependent diabetes or juvenile onset diabetes) is characterized by insufficient insulin production and the need for daily insulin ...
FGL2 and disease Studies have found that FGL2 is highly expressed in microvascular endothelial cells, causing microcirculatory disturbance, promoting myocardial and liver ischemia-reperfusion injury, arthritis, type 2 diabetic heart failure, and type 2 diabetic nephropathy; FGL2 is highly expressed in inflammatory bowel disease ...
The global Type 1 Diabetes Treatment market size was estimated to be US$ 7.02 Billion in 2022 and is geared to grow at a CAGR of 7.8% between 2023 to 2032.The Type 1 Diabetes Treatment market report is a combination of qualitative and quantitative data that highlights significant industry changes, obstacles that businesses and ...
Metformin is a classic first-line hypoglycemic agent for patients with type 2 diabetes, and is an essential drug in combination regimenes. However, as the evidence is updated, the idea of drug selection for first-line treatment is changing. ...
In addition, our previous study also found that tetrahydrocurcumin has a good therapeutic effect on metabolic syndrome, obesity type 2 diabetes, hypertension, insulin resistance syndrome and other related diseases, and has a wide range of application prospects. 1.Hypoglycemic Effect Murugan P et al. induced type 2 diabetes mouse ...
Our sublingual “insulin+” product will be positioned in a particular segment of this market : it will be prescribed for type II diabetes patients, who do not respond sufficiently to GLP-1 analogues alone. ...
The aim of this project is to develop low dose IL-2 for treatment of early onset juvenile Type I diabetes. Low dose injectable IL-2 in animal models has been shown to restore the balance between regulatory and effector T cells and, in this way, can help to reverse autoimmunity and the development of type I diabetes. Looking ...
BioLingus will position these products in the “epidemic” markets of obesity and type II diabetes : More than 400 MM people suffer from diabetes today. The global type 2 diabetes market is expected to grow to $58.7 billion by 2025, with an annual growth rate of 6.5%, according to research and ...
Liraglutide and exenatide are both belonging to the class of diabetes products called GLP-1 analogues. The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. ...
HFpEF is a complex disease which accounts for more than half of all heart failure (HF) hospital admissions and is an increasing disease burden. [1] The prevalence of HFpEF is climbing, reflecting an increasingly elderly and comorbid population, as well as reinforcing the need for more effective therapies.[2] SGLT2is are a class of anti-diabetic drugs that have demonstrated large ...
Linda Yip has been conducting research at Stanford, focusing on the identification and characterization of genes involved in the pathogenesis of Type 1 diabetes. Among other distinctions, she was selected as the 2016 recipient of its Young Investigator Award by the Network of Pancreatic Organ Donors with Diabetes. ...
He initially thought it was an allergic reaction to a new deodorant, but it wasn’t itchy, and it persisted after stopping the deodorant. The patient had a history of type 2 diabetes. On examination, a broad, well-demarcated, thin, scaly plaque was seen extending from the lateral chest over the axilla to the upper arm. ...
ByVisualDx
Med., 2018, one may not need to test themselves several times a day if it is stable type 2 diabetes and on agents (drugs) that do not cause hypoglycemia. ...
Patient History Patient is a 40-year-old female with a history of type 2 diabetes. Patient presented to the Emergency Room with a diabetic foot ulcer and infection. ...
Mitochondria play a key role in maintaining cellular health and viability, and their dysfunction not only contributes to the development of many human diseases such as neurodegenerative diseases, cardiovascular diseases, obesity and type II diabetes, but also reduces oocyte quality and early embryonic development in animals. ...